We are thrilled to announce our ground breaking Phase II results published in Addiction Journal (April 10th 2024) entitled: Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trial. https://onlinelibrary.wiley.com/doi/10.1111/add.16484 The article demonstrates
Our phase II results published in Addiction journal !
![Our phase II results published in Addiction journal ! Our phase II results published in Addiction journal !](https://www.kinnov-therapeutics.com/wp-content/uploads/2024/04/addiction_image_4-3.png)